+353-1-416-8900REST OF WORLD
+44-20-3973-8888REST OF WORLD
1-917-300-0470EAST COAST U.S
1-800-526-8630U.S. (TOLL FREE)
Sale

Middle East & Africa Precision Diagnostics Market Forecast to 2028 - COVID-19 Impact and Regional Analysis - by Type, Application, and End User

  • PDF Icon

    Report

  • 133 Pages
  • September 2022
  • Region: Africa, Middle East
  • The Insight Partners
  • ID: 5668484
UP TO OFF until Mar 31st 2024
The precision diagnostics market in Middle East & Africa is expected to grow from US$ 3,152.33 million in 2022 to US$ 6,062.61 million by 2028. It is estimated to grow at a CAGR of 11.5% from 2022 to 2028.

The precision medicine concept is being applied robustly in caring for rare diseases. Although it is more popular in oncology, it is gradually spreading to other specialties. The rising prevalence of cancer and the growing incidence of rare neurological disorders are increasing the demand for precision medicine, driving the growth of the precision diagnostics market. In addition, the rising demand for treatment procedures in oncology and other disorders is surging the adoption of treatment procedures. The genetic test is helpful in many areas of medicine as it identifies mutations or variants in the DNA. Genetic testing, for example, provides information about the risk of developing cancer and diagnose genetic conditions, such as Fragile X syndrome or Huntington's disease.
Based on the type of cancer, genomic cancer testing helps to create more personalize cancer treatment and care plans by helping patients and doctors better understand the diagnosis and reveal specific cancer drivers and market players encourage genomic cancer testing from the beginning of a diagnosis so precision medicine can be administered earlier in the treatment procedure. Thus, early diagnosis can help to promote early and optimal management of the disorders.
Moreover, the growing number of strategic collaborations between biopharmaceutical companies, to develop medicines targeted to treat a specific group of patients based on their particular needs and to provide effective treatment procedures and services, is increasing the number of clinical trials. The factors mentioned above are driving the precision diagnostics market growth.

Middle East & Africa Precision Diagnostics Market Segmentation

The Middle East & Africa precision diagnostics market is segmented by type, application, end user, and country.
  • Based on type, the market is segmented into genetic tests, esoteric tests, and others. The genetic tests segment dominated the market in 2022.
  • Based on application, the market is fragmented into oncology, cardiology, immunology, respiratory diseases, and others. The oncology segment dominated the market in 2022.
  • Based on end user, the market is segmented into hospitals, clinical laboratories, home care, and others. The clinical laboratories segment dominated the market in 2022.
  • Based on country, the market is segmented into Saudi Arabia, South Africa, the UAE, and the Rest of the Middle East & Africa. Further, Saudi Arabia dominated the market in 2022.
Some key players dominating the Middle East & Africa precision diagnostics market are Abbott, Bayer AG, Koninklijke Philips N.V., Novartis AG, QIAGEN, Quest Diagnostics Incorporated, Sanofi, Siemens Healthineers AG, and Swiss Precision Diagnostics GmbH
Frequently Asked Questions about the Middle Eastern & African Precision Diagnostics Market

What is the estimated value of the Middle Eastern & African Precision Diagnostics Market?

The Middle Eastern & African Precision Diagnostics Market was estimated to be valued at $3152.33 Million in 2022.

What is the growth rate of the Middle Eastern & African Precision Diagnostics Market?

The growth rate of the Middle Eastern & African Precision Diagnostics Market is 11.5%, with an estimated value of $6062.61 Million by 2028.

What is the forecasted size of the Middle Eastern & African Precision Diagnostics Market?

The Middle Eastern & African Precision Diagnostics Market is estimated to be worth $6062.61 Million by 2028.

Who are the key companies in the Middle Eastern & African Precision Diagnostics Market?

Key companies in the Middle Eastern & African Precision Diagnostics Market include Abbott, Bayer AG, Koninklijke Philips N.V., Novartis AG, QIAGEN, Quest Diagnostics Incorporated, Sanofi, Siemens Healthineers AG and Swiss Precision Diagnostics GmbH.

Table of Contents

1. Introduction
1.1 Study Scope
1.2 Research Report Guidance
1.3 Market Segmentation
1.3.1 MEA Precision Diagnostics Market - By Type
1.3.2 MEA Precision Diagnostics Market - By Application
1.3.3 MEA Precision Diagnostics Market - By End User
1.3.4 MEA Precision Diagnostics Market - By Country
2. MEA Precision Diagnostics Market - Key Takeaways
3. Research Methodology
3.1 Coverage
3.2 Secondary Research
3.3 Primary Research
4. MEA Precision Diagnostics Market - Market Landscape
4.1 Overview
4.2 PEST Analysis
4.2.1 MEA - PEST Analysis
4.3 Expert Opinion
5. MEA Precision Diagnostics Market - Key Market Dynamics
5.1 Key Market Drivers
5.1.1 Rising Demand for Personalized Medicine
5.1.2 Rising Application in Oncology and Other Disorders
5.2 Market Restraints
5.2.1 High Investments Involved in the R&D of Precision Medicine and Diagnostic Kits
5.3 Market Opportunities
5.3.1 Growing Advancement In Digital Solutions
5.4 Future Trends
5.4.1 Usage of Artificial Intelligence and Machine Learning in Precision Diagnostics
5.5 Impact Analysis
6. Precision Diagnostics Market- MEA Analysis
6.1 MEA Precision Diagnostics Market Revenue Forecast and Analysis
7. MEA Precision Diagnostics Market- by Type
7.1 Overview
7.2 Genetic Tests
7.2.1 Overview
7.2.2 Genetic Tests: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
7.3 Esoteric Tests
7.3.1 Overview
7.3.2 Esoteric Tests: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
7.4 Others
7.4.1 Overview
7.4.2 Others: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8. MEA Precision Diagnostics Market- by Application
8.1 Overview
8.2 Oncology
8.2.1 Overview
8.2.2 Oncology: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.3 Cardiology
8.3.1 Overview
8.3.2 Cardiology: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.4 Respiratory Diseases
8.4.1 Overview
8.4.2 Respiratory Diseases: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.5 Immunology
8.5.1 Overview
8.5.2 Immunology: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
8.6 Others
8.6.1 Overview
8.6.2 Others: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9. MEA Precision Diagnostics Market- by End User
9.1 Overview
9.2 Clinical Laboratories
9.2.1 Overview
9.2.2 Clinical Laboratories: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.3 Hospitals
9.3.1 Overview
9.3.2 Hospitals: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.4 Homecare
9.4.1 Overview
9.4.2 Homecare: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
9.5 Others
9.5.1 Overview
9.5.2 Others: MEA Precision Diagnostics Market Revenue and Forecast to 2028 (US$ Million)
10. MEA Precision Diagnostics Market- by Country
10.1 MEA: Precision Diagnostics Market- Revenue and Forecast to 2028
10.1.1 Overview
10.1.2 MEA: Precision Diagnostics Market Revenue and Forecasts to 2028, By Country (%)
10.1.2.1 Saudi Arabia: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.1 Overview
10.1.2.1.2 Saudi Arabia: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.1.3 Saudi Arabia: Precision Diagnostics Market Revenue and Forecasts to 2028, by Type (US$ Million)
10.1.2.1.4 Saudi Arabia: Precision Diagnostics Market Revenue and Forecasts to 2028, by Application (US$ Million)
10.1.2.1.5 Saudi Arabia: Precision Diagnostics Market Revenue and Forecast to 2028, By End User (US$ Million)
10.1.2.2 South Africa: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.1 Overview
10.1.2.2.2 South Africa: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.2.3 South Africa: Precision Diagnostics Market Revenue and Forecasts to 2028, by Type (US$ Million)
10.1.2.2.4 South Africa: Precision Diagnostics Market Revenue and Forecasts to 2028, by Application (US$ Million)
10.1.2.2.5 South Africa: Precision Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)
10.1.2.3 UAE: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.1 Overview
10.1.2.3.2 UAE: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.3.3 UAE: Precision Diagnostics Market Revenue and Forecasts to 2028, by Type (US$ Million)
10.1.2.3.4 UAE: Precision Diagnostics Market Revenue and Forecasts to 2028, by Application (US$ Million)
10.1.2.3.5 UAE: Precision Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)
10.1.2.4 Rest of MEA: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.1 Overview
10.1.2.4.2 Rest of MEA: Precision Diagnostics Market Revenue and Forecasts to 2028 (US$ Million)
10.1.2.4.3 Rest of MEA: Precision Diagnostics Market Revenue and Forecasts to 2028, by Type (US$ Million)
10.1.2.4.4 Rest of MEA: Precision Diagnostics Market Revenue and Forecasts to 2028, by Application (US$ Million)
10.1.2.4.5 Rest of MEA: Precision Diagnostics Market Revenue and Forecast to 2028, by End User (US$ Million)
11. MEA Precision Diagnostics Market -Industry Landscape
11.1 Overview
11.2 Organic Developments
11.2.1 Overview
11.2.2 Organic Growth Strategies in the Precision Diagnostics Market, 2018-2022
11.3 Inorganic Developments
11.3.1 Overview
11.3.2 Inorganic Growth Strategies in the Precision Diagnostics Market, 2018-2022
12. Company Profiles
12.1 Quest Diagnostics Incorporated
12.1.1 Key Facts
12.1.2 Business Description
12.1.3 Products and Services
12.1.4 Financial Overview
12.1.5 SWOT Analysis
12.1.6 Key Developments
12.2 QIAGEN
12.2.1 Key Facts
12.2.2 Business Description
12.2.3 Products and Services
12.2.4 Financial Overview
12.2.5 SWOT Analysis
12.2.6 Key Developments
12.3 Swiss Precision Diagnostics GmbH
12.3.1 Key Facts
12.3.2 Business Description
12.3.3 Products and Services
12.3.4 Financial Overview
12.3.5 SWOT Analysis
12.3.6 Key Developments
12.4 Koninklijke Philips N.V.
12.4.1 Key Facts
12.4.2 Business Description
12.4.3 Products and Services
12.4.4 Financial Overview
12.4.5 SWOT Analysis
12.4.6 Key Developments
12.5 Siemens Healthineers AG
12.5.1 Key Facts
12.5.2 Business Description
12.5.3 Products and Services
12.5.4 Financial Overview
12.5.5 SWOT Analysis
12.5.6 Key Developments
12.6 Abbott
12.6.1 Key Facts
12.6.2 Business Description
12.6.3 Products and Services
12.6.4 Financial Overview
12.6.5 SWOT Analysis
12.6.6 Key Developments
12.7 Novartis AG
12.7.1 Key Facts
12.7.2 Business Description
12.7.3 Products and Services
12.7.4 Financial Overview
12.7.5 SWOT Analysis
12.7.6 Key Developments
12.8 Sanofi
12.8.1 Key Facts
12.8.2 Business Description
12.8.3 Products and Services
12.8.4 Financial Overview
12.8.5 SWOT Analysis
12.8.6 Key Developments
12.9 Bayer AG
12.9.1 Key Facts
12.9.2 Business Description
12.9.3 Products and Services
12.9.4 Financial Overview
12.9.5 SWOT Analysis
12.9.6 Key Developments
13. Appendix
13.1 About the Publisher
13.2 Glossary of Terms

Companies Mentioned

A selection of companies mentioned in this report includes:

  • Abbott
  • Bayer AG
  • Koninklijke Philips N.V.
  • Novartis AG
  • QIAGEN
  • Quest Diagnostics Incorporated
  • Sanofi
  • Siemens Healthineers AG
  • Swiss Precision Diagnostics GmbH